Rockwell Medical (RMTI) Total Debt (2013 - 2026)
Rockwell Medical (RMTI) posted Total Debt of $8.9 million for Q1 2026, down 9.28% on a QoQ basis from $9.8 million in Q4 2025, and down 18.93% year-over-year from $11.0 million in Q1 2025.
Rockwell Medical (RMTI) Total Debt (2013 - 2026) Analysis & Trends
Rockwell Medical's Total Debt history runs 11 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- Quarterly Total Debt fell 18.93% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (down 18.93% YoY) and the FY2025 annual result came in at $9.8 million, down 9.38% from the prior year.
- Total Debt was $8.9 million for Q1 2026 at Rockwell Medical, down from $9.8 million in the prior quarter.
- Across five years, Total Debt topped out at $18.4 million in Q1 2022 and bottomed at $2.1 million in Q4 2022.
- A 5-year average of $10.0 million and a median of $10.8 million in 2024 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt sank 89.62% — and 2023, when it jumped 405.76%.
- Rockwell Medical's Total Debt stood at $2.1 million in 2022, then soared by 405.76% to $10.8 million in 2023, then climbed by 0.46% to $10.8 million in 2024, then fell by 9.38% to $9.8 million in 2025, then fell by 9.28% to $8.9 million in 2026.
- Business Quant data shows RMTI's Total Debt at $8.9 million in Q1 2026, $9.8 million in Q4 2025, and $10.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 8.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.91 Mn |
| Dec 31, 2025 | 9.83 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 11.15 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Sep 30, 2024 | 10.66 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 10.77 Mn |
| Dec 31, 2023 | 10.79 Mn |
| Sep 30, 2023 | 5.83 Mn |
| Jun 30, 2023 | 5.36 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 14.09 Mn |
| Jun 30, 2022 | 15.50 Mn |
| Mar 31, 2022 | 18.41 Mn |
| Dec 31, 2021 | 20.57 Mn |
| Sep 30, 2021 | 14.09 Mn |
| Jun 30, 2021 | 21.13 Mn |